Promoter group acquires shares via warrant conversion

Promoter Stake BuyOwnership Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+5.3%1-day move

₹67.45

prior close

—

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

————+5.3-1.4-0.7-1.5+3.4+1.1————

Up moveDown movePending

AI summary

Promoter group entity Srinidhi Fine Chemicals LLP acquired equity shares of Novelix Pharmaceuticals through conversion of warrants issued under a preferential allotment. The disclosure was filed under SEBI insider trading regulations, with the whole-time director Venkateshwarlu submitting it to BSE.

Likely market impact

Promoter buying signals confidence in the company. Likely increases promoter shareholding and reduces dilution overhang from warrants.